Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
51,534
Total Claims
$3.7M
Drug Cost
1,525
Beneficiaries
$2,454
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-97%
Opioid rate vs peers
0.1% vs 2.2% avg
+74%
Cost per patient vs peers
$2,454 vs $1,411 avg
+72%
Brand preference vs peers
18.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.1%
Opioid Rate
29
Opioid Claims
$179
Opioid Cost
41.4%
Long-Acting Rate
Brand vs Generic
Brand: 9,380 claims · $2.8M
Generic: 42,023 claims · $907K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 2,293 | $657K |
| Linagliptin | 767 | $212K |
| Insulin Glargine,hum.Rec.Anlog | 461 | $130K |
| Interferon Beta-1a/Albumin | 12 | $125K |
| Rivaroxaban | 391 | $113K |
| Insulin Lispro | 284 | $112K |
| Dulaglutide | 140 | $107K |
| Mirabegron | 384 | $88K |
| Empagliflozin | 265 | $83K |
| Insulin Aspart | 148 | $63K |
| Fluticasone/Umeclidin/Vilanter | 92 | $62K |
| Sitagliptin Phosphate | 221 | $51K |
| Sacubitril/Valsartan | 158 | $44K |
| Tiotropium Bromide | 76 | $41K |
| Atorvastatin Calcium | 3,081 | $39K |
Prescribing Profile
Patient Profile
78
Avg Age
67%
Female
2.74
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About